Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Sweden
  4. Nasdaq Stockholm
  5. Swedish Orphan Biovitrum AB (publ)
  6. Financials
    SOBI   SE0000872095

SWEDISH ORPHAN BIOVITRUM AB (PUBL)

(SOBI)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization1 52 08945 43748 34554 07054 070-
Enterprise Value (EV)1 49 09461 16162 09363 02959 68856 860
P/E ratio 21,6x13,8x15,2x22,7x24,3x18,6x
Yield ------
Capitalization / Revenue 5,70x3,19x3,17x3,55x3,35x3,05x
EV / Revenue 5,37x4,29x4,07x4,14x3,70x3,21x
EV / EBITDA 13,6x9,99x9,09x11,5x11,7x9,59x
Price to Book 5,83x2,74x2,42x2,45x2,23x2,00x
Nbr of stocks (in thousands) 269 893294 091291 059295 145295 145-
Reference price (SEK) 193155166185185185
Announcement Date 02/20/201902/13/202002/18/2021---
1 SEK in Million
Previous periodNext period
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales1 9 13914 24815 26115 22616 15417 737
EBITDA1 3 6076 1216 8305 4865 1225 927
Operating profit (EBIT)1 3 1224 5334 8183 5683 2164 055
Operating Margin 34,2%31,8%31,6%23,4%19,9%22,9%
Pre-Tax Profit (EBT)1 3 0824 2474 2173 1342 8863 764
Net income1 2 4183 3043 2452 4242 2593 015
Net margin 26,5%23,2%21,3%15,9%14,0%17,0%
EPS2 8,9311,210,98,177,619,92
Dividend per Share2 ------
Announcement Date 02/20/201902/13/202002/18/2021---
1 SEK in Million
2 SEK
Previous periodNext period
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2021 Q1 2021 Q2 2021 Q3 2021 Q4 2022 Q1 2022 Q2
Net sales1 3 6613 2113 7614 6694 4783 423
EBITDA1 1 5199571 2021 7951 4141 236
Operating profit (EBIT)1 1 0344677081 372898720
Operating Margin 28,2%14,5%18,8%29,4%20,1%21,0%
Pre-Tax Profit (EBT)1 9193545981 276845671
Net income1 696268473977652518
Net margin 19,0%8,35%12,6%20,9%14,6%15,1%
EPS2 2,330,901,593,242,211,76
Dividend per Share ------
Announcement Date 05/04/202107/21/202110/22/2021---
1 SEK in Million
2 SEK
Previous periodNext period
Balance Sheet Analysis
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt1 -15 72413 7488 9585 6172 790
Net Cash position1 2 995-----
Leverage (Debt / EBITDA) -0,83x2,57x2,01x1,63x1,10x0,47x
Free Cash Flow1 1 515-18 0511 2504 2163 2223 808
ROE (Net Profit / Equities) 30,7%25,4%17,5%11,2%9,39%10,8%
Shareholders' equity1 7 87112 98518 56821 59924 06927 807
ROA (Net Profit / Asset) 17,2%10,5%6,91%5,10%4,85%6,29%
Assets1 14 04231 42246 97047 48446 55847 950
Book Value Per Share2 33,156,468,575,483,192,6
Cash Flow per Share2 7,7212,317,514,912,914,8
Capex1 41,037,041,0117121130
Capex / Sales 0,45%0,26%0,27%0,77%0,75%0,73%
Announcement Date 02/20/201902/13/202002/18/2021---
1 SEK in Million
2 SEK
Previous periodNext period
Key data
Capitalization (SEK) 54 070 496 032
Capitalization (USD) 5 890 648 263
Net sales (SEK) 15 261 000 000
Net sales (USD) 1 661 068 284
Number of employees 1 532
Sales / Employee (SEK) 9 961 488
Sales / Employee (USD) 1 084 248
Free-Float 59,5%
Free-Float capitalization (SEK) 32 146 795 650
Free-Float capitalization (USD) 3 502 195 834
Avg. Exchange 20 sessions (SEK) 80 988 580
Avg. Exchange 20 sessions (USD) 8 815 121
Average Daily Capital Traded 0,15%
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA